These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3812676)

  • 21. Pioglitazone treatment for 7 days failed to correct the defect in glucose transport and glucose transporter translocation in obese Zucker rat (fa/fa) skeletal muscle plasma membranes.
    Hirshman MF; Fagnant PM; Horton ED; King PA; Horton ES
    Biochem Biophys Res Commun; 1995 Mar; 208(2):835-45. PubMed ID: 7695642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration.
    Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
    J Pharmacol Exp Ther; 1984 Dec; 231(3):649-53. PubMed ID: 6502518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of the rate of appearance in the non-steady state with a two-compartment model.
    Mari A
    Am J Physiol; 1992 Aug; 263(2 Pt 1):E400-15. PubMed ID: 1514623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.
    Leonard BL; Watson RN; Loomes KM; Phillips AR; Cooper GJ
    Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calculation of metabolic fluxes with anatomically separated sources of tracer and tracee.
    Norwich KH; Wasserman DH
    Am J Physiol; 1986 Dec; 251(6 Pt 1):E715-20. PubMed ID: 3538902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental validation of measurements of glucose turnover in nonsteady state.
    Radziuk J; Norwich KH; Vranic M
    Am J Physiol; 1978 Jan; 234(1):E84-93. PubMed ID: 623255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impairment of the modulation by glucose of hepatic gluconeogenesis in the genetically obese (fa/fa) Zucker rat.
    Sánchez-Gutiérrez JC; Lechuga CG; Sánchez-Arias JA; Samper B; Felíu JE
    Endocrinology; 1995 May; 136(5):1877-84. PubMed ID: 7720633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired peripheral thyroid hormone metabolism in genetic obesity.
    Katzeff HL; Selgrad C
    Endocrinology; 1993 Mar; 132(3):989-95. PubMed ID: 8440199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choice and use of tracers.
    Butler P; Bell P; Rizza R
    Horm Metab Res Suppl; 1990; 24():20-5. PubMed ID: 2272622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The accuracy of measurement required for acceptable estimation of non-steady rates of appearance and disappearance by the tracer method using a two-compartment model.
    Wootton R; Flecknell PA; John M
    Clin Phys Physiol Meas; 1983 Feb; 4(1):39-46. PubMed ID: 6831841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes.
    Matthaei S; Reibold JP; Hamann A; Benecke H; Häring HU; Greten H; Klein HH
    Endocrinology; 1993 Jul; 133(1):304-11. PubMed ID: 8391425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose transport: locus of muscle insulin resistance in obese Zucker rats.
    Sherman WM; Katz AL; Cutler CL; Withers RT; Ivy JL
    Am J Physiol; 1988 Sep; 255(3 Pt 1):E374-82. PubMed ID: 3138916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise, unlike insulin, promotes glucose transporter translocation in obese Zucker rat muscle.
    King PA; Betts JJ; Horton ED; Horton ES
    Am J Physiol; 1993 Aug; 265(2 Pt 2):R447-52. PubMed ID: 8368400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic characteristics of the obese overfed rat.
    Corcoran GB; Salazar DE; Sorge CL
    Int J Obes; 1989; 13(1):69-79. PubMed ID: 2703295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.
    Phelps ME; Huang SC; Hoffman EJ; Selin C; Sokoloff L; Kuhl DE
    Ann Neurol; 1979 Nov; 6(5):371-88. PubMed ID: 117743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach.
    Natali A; Gastaldelli A; Camastra S; Sironi AM; Toschi E; Masoni A; Ferrannini E; Mari A
    Am J Physiol Endocrinol Metab; 2000 May; 278(5):E794-801. PubMed ID: 10780934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local cerebral glucose utilization in brains of lean and genetically obese (fa/fa) rats.
    Doyle P; Rohner-Jeanrenaud F; Jeanrenaud B
    Am J Physiol; 1993 Jan; 264(1 Pt 1):E29-36. PubMed ID: 8430785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic or inert metabolism? Turnover of N-acetyl aspartate and glutathione from D-[1-13C]glucose in the rat brain in vivo.
    Choi IY; Gruetter R
    J Neurochem; 2004 Nov; 91(4):778-87. PubMed ID: 15525331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of gluconeogenesis by epinephrine in hepatocytes isolated from genetically obese (fa/fa) Zucker rats.
    Sánchez-Gutiérrez JC; Sánchez-Arias JA; Samper B; Felíu JE
    Arch Biochem Biophys; 2000 Jan; 373(1):249-54. PubMed ID: 10620345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.